The researcher Xavier Bosch, head of the group on Viruses and Cancer at IDIBELL and Director of the Research in Cancer Epidemiology program at the Catalan Institute of Oncology (ICO), has been awarded the Lilly Foundation for Biomedical Research award 2012 in the category preclinical research. The Lilly Foundation has highlighted the contribution of Xavier […]
Xavier Bosch, Lilly Biomedical Research Award 2012 Read More »
Nature Biotech publishes in its latest issue an article about the European project Blueprint that was launched last October and aims to generate epigenomic maps of up to one hundred different types of blood cells to help researchers understand how the epigenome influences health and disease. The Cancer Epigenetics and Biology Program of IDIBELL, led
Nature Biotech calls ”signal of a new era in biomedical research” the BLUEPRINT project Read More »
The study of the molecular mechanisms that regulate the signaling pathways of transforming growth factor (TGF-beta) is the field of action of Peter Ten Djike and his research group at the University of Leiden, the Netherlands. Ten Djike explained their latest developments in a lecture in the seminar series IDIBELL on March 2. TGF-beta is
Researchers of the Epigenetics and Cancer Biology program at IDIBELL, led by Manel Esteller, participate in the European project DEXLIFE that aims research new ways to detect and prevent type 2 diabetes. The project funded with 5.5 million euros by the European Union within the 7th Framework Programme for Research and Development will take place
IDIBELL participates in a European project to detect and prevent type 2 diabetes Read More »
Metastasis is responsible for 90% of deaths in patients with cancer. So understand the mechanisms responsible for this process are one of the top goals of cancer research. The metastatic process involves a series of steps chained where the primary tumor invades surrounding tissue and ends spreading throughout the body. One of the first tissues
The loss of a protein makes ‘jump’ the tumor to the lymph node Read More »
C. elegans is a nematode that measures millimetre of length, approximately. It has been used to study the genetics of development and the nervous system, and in recent years is making contributions to the study of aging, cell death and genome structure. In 1998 it has been published the complete sequence of its genome, comprising
IDIBELL launches ‘Caenorhabditis elegans’ Facility Read More »
The director of the Center for Genomic Regulation (CRG) in Barcelona, Luis Serrano, explained the latest developments of his research group on Systems Biology in a conference of the series of seminars IDIBELL on February 24. One of the highlights of the Serrano team is to study proteins, not as single molecules, but as parts
The researcher of the Thomas J. Watson Research Center, IBM Research in New York, Pablo Meyer, explained in a special seminar on 16 February his research on the regulation of cellular metabolism based on the distribution of enzymes and mitochondria in the cytoplasm. Meyer and his team have shown in E.coli that the location and
The research group New Therapies on Genes and Transplantation at the IDIBELL first studied the response of human NK cells (Natural Killer) against porcine chondrocytes (cartilage cells). The results of the research, published in The Journal of Immunology, indicate that these cells, characteristic of the innate immune system play an important role in the rejection
Factors influencing Citomeglaovirus infection (CMV) and how to prevent it focused the conference of the researcher at the Institute for Biomedical Research Hospital Universitario 12 de Octubre in Madrid, Jose Maria Aguado, in IDIBELL seminar series on 17 February. CMV is an herpes virus that affects the vast majority of patients with solid organ transplantation.
